TNF and inflammatory bowel disease: The initial work involved creating foundational nanoparticle systems, including a mannosylated bioreducible cationic polymer that designed to efficiently targets macrophages and inhibit TNF-α expression, thereby effectively treating IBD (Xiao et al., 2013).